Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,445.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.139%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,445.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Galliford Rises As Dividend Set To Return

Fri, 13th Nov 2020 11:13

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Whitbread, up 1.8%. Barclays upgraded Whitbread to Overweight from Equal Weight, deeming the Premier Inn hotel chain owner one of the most attractive stocks in the hospitality sector following this week's positive coronavirus vaccine news.

----------

FTSE 250 - WINNERS

----------

Royal Mail, up 4.0%. Credit Suisse upgraded the postal operator to Neutral from Underperform.

----------

FTSE 250 - LOSERS

----------

Indivior, down 2.5%. The drugmaker said a US federal court in the Western District of Virginia has approved the agreement between the pharmaceuticals firm and the US Department of Justice over resolving criminal charges in the US related to its Suboxone film opioid dependence medication. In mid-July, Indivior agreed to part with USD600 million to resolve the charges with the US Justice Department. In April 2019 a grand jury in the Western District of Virginia had issued an indictment of 28 felony counts against the company related to fraud. In a statement Friday, Indivior noted the federal court has dismissed all of these charges. Indivior could have faced USD3 billion in fines related to the matters. "As previously noted, Indivior is pleased to put this matter behind it and move forward in a manner that provides certainty to its business," the firm said. The stock is three times higher since the start of 2020.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Galliford Try Holdings, up 23%. The construction company said productivity has been at "near-normal levels" since the start of its financial year on July 1, with the construction firm saying it will continue to operate "normally during the second national lockdown" in England. Galliford said it is performing in line with its expectations, with an "excellent" first half-year average month-end cash position towards the upper end of previous guidance of GBP125 million to GBP145 million. "The board expects the group to return to profitability in the first half of this financial year and a resumption of dividend with the interim results," Galliford said. In financial 2020, no final dividend was declared, following Galliford's decision to cancel the interim dividend in March. The full year dividend for financial 2019 was 58.0 pence.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Nakama Group, down 29%. The recruitment consultancy said its recent trading has been in line with management expectations but remains "difficult", and it is concerned about cashflow. Nakama previously had guided for revenue in the year ending March 31 to drop 28% year on year to GBP9.7 million from GBP13.4 million. "The Covid-19 pandemic had an immediate and significant impact on the group's trading activities. The company has utilised a number of government initiatives in the UK, Hong Kong and Singapore in order to preserve cash and retain the businesses ability to continue to trade," Nakama said. Rising virus infections has led to a second national lockdown in the UK, which Nakama said means its "market conditions remain difficult".

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2021 12:17

Indivior lifts FY guidance as Q3 profits, revenue jump

(Sharecast News) - Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.

Read more
24 Oct 2021 17:12

Sunday share tips: Light Science Technologies, Indivior

(Sharecast News) - The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.

Read more
31 Aug 2021 09:38

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

Read more
11 Aug 2021 16:08

Director dealings: Indivior director ups stake

(Sharecast News) - Indivior revealed on Wednesday that non-executive director Mark Stejbach had acquired 36,000 ordinary shares in the FTSE 250-listed pharmaceuticals business.

Read more
10 Aug 2021 15:07

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

Read more
9 Aug 2021 13:03

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

Read more
5 Aug 2021 15:29

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

Read more
4 Aug 2021 14:23

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

Read more
30 Jul 2021 12:28

IN BRIEF: Indivior to commence USD100 million share repurchase program

IN BRIEF: Indivior to commence USD100 million share repurchase program

Read more
29 Jul 2021 15:37

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

Read more
29 Jul 2021 12:13

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

Read more
29 Jul 2021 08:48

Indivior launches share buyback after strong first half

(Sharecast News) - Speciality pharmaceuticals company Indivior reiterated its upgraded guidance for 2021 on Thursday, and announced the start of a $100m (£71.71m) share buyback programme, as its first-half net revenue rose to $381m from $303m year-on-year.

Read more
22 Jul 2021 16:03

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Jul 2021 14:00

Indivior agrees new loan facilities of USD250 million maturing in 2026

Indivior agrees new loan facilities of USD250 million maturing in 2026

Read more
1 Jul 2021 10:33

Indivior agrees to reprice and extend maturity of term loan facilities

(Sharecast News) - Pharmaceutical firm Indivior said on Thursday that it had entered into an amendment to reprice and extend the maturity of $250.0m worth of term loan facilities.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.